EcoDrugPlus

Protein Kinase C Epsilon

Ensembl ID : ENSCVAG00000002727
Gene Symbol: PRKCE
3 Cross references
259 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSCVAG00000018619
Gene Symbol: PRKCI
3 Cross references
270 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSCVAG00000001315
Gene Symbol: PRKCQ
3 Cross references
205 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSCVAG00000007182
Gene Symbol: PRKCZ
3 Cross references
205 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSCVAG00000018206
Gene Symbol: PRKD1
3 Cross references
210 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSCVAG00000009028
Gene Symbol: PRKD3
3 Cross references
218 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSCVAG00000004759
Gene Symbol: PRKDC
3 Cross references
187 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSCVAG00000015759
Gene Symbol: PPP3CA
4 Cross references
233 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSCVAG00000003044
Gene Symbol: PTK2
3 Cross references
241 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta

Ensembl ID : ENSCVAG00000022965
Gene Symbol: PTK2B
3 Cross references
196 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11

Ensembl ID : ENSCVAG00000006513
Gene Symbol: PTPN11
3 Cross references
253 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSCVAG00000012244
Gene Symbol: PTPRB
4 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).